DTB-Navarre published an assessment report entitled “Dronedarone (Multaq®) for non-permanent atrial fibrillation. Lower efficacy than amiodarone and a questionable safety profile” (2011, No 5). Excerpt (…) “Its safety profile is far from established. An increase in mortality in patients with heart...
By Stephen Hume, Vancouver Sun June 30, 2011 A letter from 24 eminent physicians, researchers, ethicists and medical school professors objects strenuously to a Canadian advertising campaign that the group says promotes the benefits of a testosterone...
May 2011 This report on Canada's health care performance is a pan-Canadian look at five key commitments of the 2003 First Ministers' Accord on Health Care Renewal and the 2004 10- Year Plan to Strengthen Health...
Drug and Therapeutics Bulletin The Independent Review of Medical Treatment Vol 49 | No 2 | February 2011 Ever since the concept of the ‘polypill’ was introduced,1,2 it has maintained an almost magical hold over the lay press and many healthcare...